GSK

Showing 15 posts of 736 posts found.

top_10_image

Top Ten most popular articles on Pharmafile.com this week!

July 12, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, HPV, NHS, NICE, Novartis, Pfizer, Trump, pharma, vaccines

This week’s most popular story covered news of Trump’s claims that he will introduce an executive order to ensure the …

1920px-hiv-budding-color

ViiV Healthcare’s two drug HIV therapy beats Gilead’s three drug treatment in Phase 3 trial

July 10, 2019
Research and Development AIDS, Dovato, GSK, Gilead, HIV, ViiV, pharma

Pfizer and GlaxoSmithKline’s HIV company, ViiV Healthcare, has said its two-drug combo Dovato (dolutegravir and lamuvidine) met its primary endpoint …

landing-hero-images1

ViiV’s Dovato approved in Europe as treatment option for HIV-1

July 3, 2019
Research and Development, Sales and Marketing Dovato, GSK, HIV, ViiV Healthcare, pharma

ViiV Healthcare, the specialist HIV firm majority owned by GSK, is celebrating the news that the European Commission has chosen …

shutterstock_235920349

GSK offers concessions ahead of planned venture with Pfizer

June 21, 2019
Medical Communications, Sales and Marketing GSK, Pfizer, pharma

The European Commission has said that GlaxoSmithKline has offered concessions to address concerns relating to the British multinational’s planned joint …

gsk_china_2_2_0_1

GSK launch sale of consumer healthcare brands

June 20, 2019
Business Services GSK, Pfizer, consumer health, pharma, portfolio

British multinational GlaxoSmithKline (GSK) has launched a sale of some of its consumer healthcare brands. The sale comes as GSK …

top_10_image

Top Ten most popular articles on Pharmafile.com this week!

June 14, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, GSK, J&J, JJ, Otsuka, Pfizer, Purdue, Sanofi, Vertex, pharma

Pfizer supressed research showing their arthritis drug Enbrel reduced the risk of Alzheimer’s. This was the big revelation this week! …

800px-uc-berkeley-campus-overview-from-hills

GSK sets up new CRISPR lab with UC, Berkeley

June 13, 2019
Medical Communications GSK, UC, berkely, crispr, genetics, pharma

GSK has struck a $67 million deal with the University of California, Berkeley. British multinational GlaxoSmithKline will collaborate with UC, …

top_10_image

Top Ten most popular articles on Pharmafile.com this week!

May 31, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, FDA, GSK, Novartis, Pfizer, environment, opioids, pharma, pricing

The pharmaceutical industry is a big polluter than the automotive industry. This was our top story this week. The findings …

190131111631-01-shingles-vaccine-gsk-super-tease

China approves GSK’s shingles vaccine Shingrix

May 24, 2019
Medical Communications, Sales and Marketing China, GSK, Shingrix, pharma, shingles

GSK’s shingles vaccine has secured approval in China, the company said, after the National Medical Products Administration (NMPA) authorised the …

gsk_boronia_australia

GSK to reintroduce bonuses for sales reps

May 24, 2019
Medical Communications GSK, US, oncology, pharma, sales, sales reps, scandal

British multinational GlaxoSmithKline said on Thursday that it would reintroduce performance-based bonuses for some sales reps in some countries. The …

top_10_image

Top Ten most popular articles on Pharmafile.com this week!

May 10, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, GSK, Innoviva, NHS, Novartis, health, migraine, pharma

This week was a particularly bad one for the NHS after it was revealed thousands of EU nurses were leaving …

shutterstock_232245868

GSK and Innoviva’s triple asthma therapy Trelegy Ellipta impresses at Phase 3

May 3, 2019
Medical Communications, Research and Development GSK, Innoviva, Trelegy, ellipta, pharma

GSK and partner Innoviva have lifted the curtain on new Phase 3 data for their single inhaler triple therapy Trelegy …

gsk_boronia_australia

GSK’s Benlysta becomes first FDA-approved IV therapy for paediatric lupus

April 30, 2019
Manufacturing and Production, Sales and Marketing Benlysta, FDA, GSK, Lupus, US, pharma

GSK has scored approval in the US with Benlysta (belimumab) for the treatment of systemic lupus erythematosus (SLE) in paediatric …

Latest content